BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q2 2023 Earnings Call Transcript July 31, 2023
BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.54, expectations were $0.23.
Operator: Thank you for joining BioMarin Second Quarterly Results Conference Call. Hosting today’s call from BioMarin is Traci McCarty, Head of Investor Relations at BioMarin. Please go ahead, Traci.
Traci McCarty: Thank you, Katie, and thank you, everyone for joining us today. To remind you, this...
